| Trial ID: | L0334 |
| Source ID: | NCT01150201
|
| Associated Drug: |
Aliskiren
|
| Title: |
Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Disease
|
| Interventions: |
DRUG: Aliskiren|DRUG: Losartan
|
| Outcome Measures: |
Primary: Rate of change in GFR, 36 months | Secondary: Change in proteinuria, 36 months
|
| Sponsor/Collaborators: |
Sponsor: The University of Hong Kong
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2014-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-03
|
| Locations: |
Queen Mary Hospital, Hong Kong, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01150201
|
